GLAXF GSK plc

NEUTRAL Impact: 3/10 6-K
Horizon weeks Filed Apr 21, 2026 Processed 1mo ago SEC 0001654954-26-003750
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GLAXF ▼ -12.88% at T+20d
NEUTRAL call ✗ call lost -12.88% · α vs SPY -17.80% · entry $29.50 → $25.70
Next anchor: T+60d in 5w
Last close $24.66 (close Jun 8) · -16.41% from $29.50 entry
Entry anchored
Apr 21, 2026
via day open
T+1d
-7.76%
call -7.76% · α -8.78%
$27.21
settled 7w ago
T+5d
-10.51%
call -10.51% · α -11.59%
$26.40
settled 6w ago
T+20d
-12.88%
call -12.88% · α -17.80%
$25.70
settled 22d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

GSK plc repurchased 330,000 ordinary shares on April 20, 2026, at a volume-weighted average price of 2,141.19 GBp per share, as part of its existing buyback program. This brings the total repurchased under the program since February 17, 2026, to 20,186,521 shares.

Actionable Insight

Monitor the next quarterly filing for updates on the total buyback program expenditure and its impact on outstanding shares. The current repurchase is part of an ongoing program and does not signal a change in strategy.

Key Facts

  • GSK repurchased 330,000 ordinary shares on April 20, 2026.
  • The volume-weighted average price paid was 2,141.19 GBp per share.
  • The shares were purchased through BNP Paribas SA as part of a non-discretionary agreement.
  • Since February 17, 2026, GSK has purchased a total of 20,186,521 shares under this buyback program.
  • The repurchased shares will be held as treasury shares.

Financial Impact

The repurchase of 330,000 shares at an average price of 2,141.19 GBp represents a total expenditure of approximately £7.07 million.

dilution

Risk Factors

  • The buyback program may be subject to changes in market conditions or company strategy.
  • The actual impact on earnings per share will depend on the total number of shares repurchased and the program's completion.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003750
Document: 0001654954-26-003750-index-headers.html0001654954-26-003750
Document: 0001654954-26-003750-index.html0001654954-26-003750
Document: 0001654954-26-003750.txt0001654954-26-003750
50 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 9, 2026
today
6-K
NEUTRAL ★ 1/10
awaiting T+5
Jun 9, 2026
today
6-K
BULLISH ★ 7/10
awaiting T+5
Jun 1, 2026
8d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$24.66 (+1.69%)
Jun 1, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$24.66 (+1.69%)
May 28, 2026
12d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$24.66 (+0.33%)
May 27, 2026
13d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$24.66 (−3.56%)
May 26, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$24.66 (−3.29%)
May 26, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$24.66 (−3.29%)
May 22, 2026
18d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$24.66 (−5.15%)
May 20, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$25.70 $25.57▼ −0.51%▼ −1.74%$24.66 (−4.05%)
Showing 10 of 50

US Market Status

Market Closed — Opens in 7h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access